Medicare Enrolled
Dr. John Dudzinski, D.O.
Family Medicine · North East, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dudzinski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dudzinski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dudzinski
Dr. John Dudzinski is a family medicine specialist in North East, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dudzinski performed 1,627 Medicare services across 1,055 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dudzinski received a total of $28,300 from 61 pharmaceutical and/or device companies across 1244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dudzinski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in PA
$28,300 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,627
Medicare services
Top 12% in PA for family medicine
1,055
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~81 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
489 | $55 | $90 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
411 | $6 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $72 | $128 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
174 | $126 | $250 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
91 | $10 | $22 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
81 | $29 | $36 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
74 | $72 | $80 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
19 | $9 | $40 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
19 | $29 | $34 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
17 | $162 | $170 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
16 | $281 | $322 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
14 | $2 | $5 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $209 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,300
Total received (2018-2024)
Avg $4,043/year across 7 years
Top 1% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,244
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,502 (61.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,799 (38.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,202
2023
$2,574
2022
$2,781
2021
$3,127
2020
$8,962
2019
$5,811
2018
$2,843
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$435
ABBVIE INC.
$310
AstraZeneca Pharmaceuticals LP
$292
Novo Nordisk Inc
$234
Amgen Inc.
$208
Exact Sciences Corporation
$138
Lilly USA, LLC
$134
Merck Sharp & Dohme LLC
$88
Bayer Healthcare Pharmaceuticals Inc.
$63
GlaxoSmithKline, LLC.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Novartis Pharmaceuticals Corporation
$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35
Phathom Pharmaceuticals, Inc.
$33
Astellas Pharma US Inc
$25
Noven Therapeutics, LLC
$24
Mylan Specialty L.P.
$20
Medtronic, Inc.
$20
Janssen Pharmaceuticals, Inc
$15
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$13,065
Lilly USA, LLC
$1,570
AstraZeneca Pharmaceuticals LP
$1,422
GlaxoSmithKline, LLC.
$1,393
Novo Nordisk Inc
$1,333
Boehringer Ingelheim Pharmaceuticals, Inc.
$952
Merck Sharp & Dohme Corporation
$755
Amgen Inc.
$725
Janssen Pharmaceuticals, Inc
$549
AbbVie Inc.
$548
ABBVIE INC.
$504
Biohaven Pharmaceuticals, Inc.
$431
Takeda Pharmaceuticals U.S.A., Inc.
$424
Merck Sharp & Dohme LLC
$399
Exact Sciences Corporation
$282
Novartis Pharmaceuticals Corporation
$271
Astellas Pharma US Inc
$266
ABIOMED
$252
E.R. Squibb & Sons, L.L.C.
$240
Bayer HealthCare Pharmaceuticals Inc.
$237
Amarin Pharma Inc.
$226
Abbott Laboratories
$216
SANOFI-AVENTIS U.S. LLC
$178
Biohaven Pharmaceutical Holding Company Ltd.
$166
Ironshore Pharmaceuticals Inc.
$156
Teva Pharmaceuticals USA, Inc.
$138
Eisai Inc.
$126
AbbVie, Inc.
$117
Bayer Healthcare Pharmaceuticals Inc.
$110
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$107
Allergan Inc.
$99
Corcept Therapeutics
$89
Corium, LLC
$76
Almatica Pharma LLC
$72
SANOFI PASTEUR INC.
$69
Daiichi Sankyo Inc.
$63
Shire North American Group Inc
$63
Dexcom, Inc.
$54
Allergan, Inc.
$53
Seqirus USA Inc
$48
Genentech USA, Inc.
$42
Supernus Pharmaceuticals, Inc.
$41
Kowa Pharmaceuticals America, Inc.
$40
Phathom Pharmaceuticals, Inc.
$33
Sunovion Pharmaceuticals Inc.
$30
Flexion Therapeutics, Inc.
$26
Inspire Medical Systems, Inc.
$24
Noven Therapeutics, LLC
$24
IDORSIA PHARMACEUTICALS US INC
$22
Mylan Specialty L.P.
$20
Medtronic, Inc.
$20
Biogen, Inc.
$18
DEXCOM, INC.
$16
Esperion Therapeutics, Inc.
$14
ShockWave Medical, Inc
$14
Medtronic Vascular, Inc.
$14
HARTMANN USA, INC.
$13
Adlon Therapeutics L.P.
$13
Grifols USA, LLC
$11
Nalpropion Pharmaceuticals LLC
$11
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · ADUHELM · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · AirDuo Digihaler · Androgel · Azstarys · BASAGLAR · BELSOMRA · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · CAMZYOS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Euphora · FARXIGA · FASENRA · FLECTOR · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · Fluad · Fluad Quadrivalent · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GRALISE · INSPIRE · INTELLIS ADAPTIVESTIM · INVOKANA · Impella · JANUVIA · JARDIANCE · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LOREEV XR · LYRICA · Legacy · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Morphabond ER · Myrbetriq · NEXLETOL · NO PRODUCT DISCUSSED · NUCALA · NURTEC ODT · OFEV · Otezla · Ozempic · PAXLOVID · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PULMICORT TURBUHALER · Proclaim Family of SCS IPGs · Proclaim IPG · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · REYVOW · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · UBRELVY · VAXELIS · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · XARELTO · XIENCE V · XIFAXAN · Xelstrym · Xofluza · YUPELRI · Zetuvit Plus · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
261
Per 100K population
96.8
County median income
$61,476
Nearest hospital
ERIE VA MEDICAL CENTER
11.9 mi
11.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dudzinski is a clinical cardiology specialist, with above-average Medicare volume (top 12% in PA), with low-engagement industry engagement in the top 1% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dudzinski experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Dudzinski performed 489 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dudzinski receive payments from pharmaceutical companies?
Yes. Dr. Dudzinski received a total of $28,300 from 61 companies across 1,244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dudzinski's costs compare to other family medicine physicians in North East?
Dr. Dudzinski's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dudzinski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in North East
Browse family medicine physicians in North East ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology